Institution statistics

FUNDACIó INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS - Spain 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 10
As coordinator: 0
As participant: 6
Sole participant: 4
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 2.060.800 110.400 1
2019 308.122 3.999.601 459.372 2 1
2018 158.122 0 158.122 1
2017 0 20.200.000 153.348 1
2016 0 5.825.128 2.495.746 2
2015 0 3.896.559 234.102 1
2014 100.000 0 100.000 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
NESTEC2
UNIVERSITY OF NEWCASTLE UPON TYNE2
4 SC1
4SC DISCOVERY1
ABBVIE INC1
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS1
AMGEN1
ASSERTA GLOBAL HEALTHCARE SOLUTIONS1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASSOCIAZIONE HAND IN HAND1
BARTS AND THE LONDON NHS TRUST1
BAYER PHARMA1
BIOBAM BIOINFORMATICS SL1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE1
CELGENE MANAGEMENT SARL1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CHARLES UNIVERSITY PRAGUE1
CHRONOS THERAPEUTICS LIMITED1
CLICLAB TRANSFORMATIVE AGENT SL1
CLINICA MEDITERRANEA1
CONSIGLIO NAZIONALE DELLE RICERCHE1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
EPIGEM LIMITED1
EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL1
EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION1
EUROPEAN HEMATOLOGY ASSOCIATION1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
EUROPEAN RESEARCH INITIATIVE ON CLL EV1
FONDAZIONE ITALIANA SINDROMI MIELODISPLASTICHE ETS1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
FUNDACION HOSPITAL LA FE1
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON1
FUNDACION MARIA CECILIA DE AYUDA AL NINO ONCOLOGICO1
FUNDACION NATALI DAFNE FLEXER1
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA1
FUNDACION PEREZ SCREMINI1
GENOME RESEARCH1
GMV SOLUCIONES GLOBALES INTERNET SAU1
GPOH GEMEINNUTZIGE1
GROUP FOR RESEARCH ON ADULT ACUTE LYMPHOBLASTIC LEUKEMIA1
GROUPE FRANCOPHONE DES MYELODYSPLASIES1
HEINRICHHEINEUNIVERSITAET DUESSELDORF1
HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT1
HOSPITAL DE PEDIATRIA SAMIC PROF DR JUAN P GARRAHAN1
HOSPITAL SANT JOAN DE DEU1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
ISTITUTO SUPERIORE DI SANITA1
JANSSEN PHARMACEUTICA NV1
JENACELL1
JOHANN WOLFGANG GOETHEUNIVERSITATFRANKFURT AM MAIN1
KAROLINSKA INSTITUTET1
LEUKANET EV1
LUDWIGMAXIMILIANSUNIVERSITAET MUENCHEN1
MASARYKOVA UNIVERZITA1
MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV1
MEDISAPIENS OY1
MEDIZINISCHE UNIVERSITAET WIEN1
MENARINI RICERCHE1
MLL MUNCHNER LEUKAMIELABOR1
MULTIPLE IMAGE TOOLS1
NANION TECHNOLOGIES1
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE1
NOVARTIS PHARMA1
OPTOROBOTIX APS1
OSPEDALE PEDIATRICO BAMBINO GESU1
PERCUROS BV1
PROGREDUM1
PULSERAS CANDELA1
RHEINISCHE FRIEDRICHWILHELMSUNIVERSITAT BONN1
SERVICIO DE SALUD METROPOLITANO NORTE1
ST ANNA KINDERKREBSFORSCHUNG1
STICHTING SANQUIN BLOEDVOORZIENING1
STICHTING VUMC1
STIFTUNG ELN FOUNDATION1
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL1
TACIT BIO INNOVATION LIMITED1
TAKEDA DEVELOPMENT CENTRE EUROPE1
TECOBIOSCIENCES1
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE1
THE LYMPHOMA STUDY ASSOCIATION1
UNIVERSIDAD DE NAVARRA1
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II1
UNIVERSITA DEGLI STUDI DI PAVIA1
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA1
UNIVERSITA DEGLI STUDI DI TORINO1
UNIVERSITAET INNSBRUCK1
UNIVERSITAET ULM1
UNIVERSITAET ZUERICH1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1
UNIVERSITAT DES SAARLANDES1
UNIVERSITAT ROVIRA I VIRGILI1
UNIVERSITATEA DE MEDICINA SI FARMACIE IULIU HATIEGANU CLUJNAPOCA1
UNIVERSITY OF BOLOGNA1
UNIVERSITY OF BRISTOL1
UNIVERSITY OF HELSINKI1
UNIVERSITY OF YORK1
Constancy:

Total number of partners:107

Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 107

Frequent / Rare Partner Ratio: 0

Diversity:

Subjects:
Subject:No:
LIFE SCIENCES1
Diversity index:1
Categories:
Category:No:
BIOLOGICAL SCIENCES1

Project overview:

Start dateProjectacronymrolefundingpartners
2020-05-01DevelOpmeNt of Cancer RNA TherapEutics cONCReTEparticipant2.060.80017
2019-01-01Acute Myeloid Leukemia Leukemic Initiating Cells: Contribution of hypoxia/HIF pathway to chemoresistance and relapse HifLICscoordinator158.1221
2019-01-01Childhood Leukemia: Overcoming distance between South America and Europe Regions CLOSERparticipant3.999.60114
2019-01-01Therapeutic immunotherapy targeting NG2 and CD22 antigens for MLL-rearranged and MLL-germline B-cell Acute Lymphoblastic Leukemia IT4B-ALLcoordinator150.0001
2018-04-01Innovative Therapeutic Strategies for Mixed Lineage Leukemia-rearranged B-cell Acute Lymphoblastic Leukemia InTheMLLrBALLcoordinator158.1221
2017-01-01Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 HARMONYparticipant20.200.00053
2016-03-01Chromatin and Metabolism Chromatin-metabolism interactions as targets for healthy living ChroMeparticipant3.825.12814
2016-01-01GENOMIC, CELLULAR AND DEVELOPMENTAL RECONSTRUCTION OFINFANT MLL-AF4+ ACUTE LYMPHOBLASTIC LEUKEMIA INFANTLEUKEMIAparticipant2.000.0001
2015-09-01Regulation of red cell life-span, erythropoiesis, survival, senescence and clearance RELEVANCEparticipant3.896.55914
2014-05-01Cell of origin/Leukemia Initiating Cell in infant Pro-B MLL-AF4+ ALL MODELING MLL-AF4 ALLcoordinator100.0001
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum